KRAS mutations (hot spot missense mutations in exon 2 codon 12, 13, and 61) have been observed in multiple tumor types, including pancreatic (> 90%), colon (45%), and lung cancers (35%)4. This evidence concerns the gene KRAS and neoplasm.